1. JanoffEN, SmithPD. Emerging concepts in gastrointestinal aspects of HIV‐pathogenesis and management. Gastroenterology2001;120:607. CrossRef

2. WolinskySM, WikeCM, KorberBTM, et al. Selective transmission of human immunodeficiency virus type‐1 variants from mothers to infants. Science1992;255:1134. CrossRef

3. ZhuT, MoH, WangN, et al. Genotypic and phenotypic characterization of HIV‐1 in patients with primary infection. Science1993;261:1179. CrossRef

4. MengG, WeiX, WuX, et al. Primary intestinal epithelial cells selectively transfer R5 HIV‐1 to CCR5+ cells. Nat Med2002;8:150. CrossRef

5. MengG, SellersM, Mosteller‐BarnumM, et al. Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa. J Infect Dis2000;182:785. CrossRef

6. VeazeyRS, ThamIC, MansfieldKG, et al. Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo. J Virol2000;74:57. CrossRef

7. ShenR, MengG, OchsenbauerC, et al. Stromal down‐regulation of macrophage CD4/CCR5 expression and NF‐κB activation mediates HIV‐1 non‐permissiveness in intestinal macrophages. PLoS Pathog2011;7:e1002060. CrossRef

8. SmithPD, FoxCH, MasurH, et al. Quantitative analysis of mononuclear cells expressing human immunodeficiency virus type 1 RNA in esophageal mucosa. J Exp Med1994;180:1541. CrossRef

9. BrenchleyJM, SchackerTW, RuffLE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med2004;200:749. CrossRef

10. MehandruS, PolesMA, Tenner‐RaczK, et al. Primary HIV‐1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med2004;200:761. CrossRef

11. LiQ, DuanL, EstesJD, et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature2005;434:1148.

12. MehandruS, PolesMA, Tenner‐RaczK, et al. Mechanisms of gastrointestinal CD4+ T‐cell depletion during acute and early human immunodeficiency virus type 1 infection. J Virol2007;81:599. CrossRef

13. SchneiderT, JahnHU, SchmidtW, et al. Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group. Gut1995;37:524. CrossRef

14. VeazeyRS, DeMariaM, ChalifouxLV, et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science1998;280:427. CrossRef

15. Smit‐McBrideZ, MattapallilJJ, McChesneyM, et al. Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4+ T‐cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes. J Virol1998;72:6646.

16. BrenchleyJM, PriceDA, SchackerTW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med2006;12:1365. CrossRef

17. NazliA, ChanO, Dobson‐BelaireWN, et al. Exposure to HIV‐1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog2010;6:e1000852. CrossRef

18. Vujkovic‐CvijinI, DunhamRM, IwaiS, et al. Dysbiosis of the gut microbiota is associated with hiv disease progression and tryptophan catabolism. Sci Transl Med2013;5:193ra91.

19. ClarkSJ, SaagMS, DeckerWD, et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV‐1 infection. NEJM1991;324:954. CrossRef

20. CohenMS, ShawGM, McMichaelAJ, et al. Acute HIV‐1 Infection. NEJM2011;364:1943. CrossRef

21. KotlerDP, GaetzHP, LangeM, et al. Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med1984;101:421. CrossRef

22. GreensonJK, BelitsosPC, YardleyJH, et al. AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhea. Ann Intern Med1991;114:366. CrossRef

23. CananiRB, CirilloP, MallardoG, et al. Effects of HIV‐1 Tat protein on ion secretion and on cell proliferation in human intestinal epithelial cells. Gastroenterology2003;124:368. CrossRef

24. HandleySA, ThackrayLB, ZhaoG, et al. Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome. Cell2012;151:253. CrossRef

25. SmithPD, LaneHC, GillVJ, et al. Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy. Ann Intern Med1988;108:328. CrossRef

26. LaughonBE, DruckmanDA, VernonA, et al. Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology1988;94:984.

27. CarcamoC, HootonT, WenerMH, et al. Etiologies and manifestations of persistent diarrhea in adults with HIV‐1 infection: a case‐control study in Lima, Peru. J Infect Dis2005;191:11. CrossRef

28. SanchezTH, BrooksJT, SullivanPS, et al. Bacterial diarrhea in persons with HIV infection, United States, 1992‐2002. Clin Infect Dis2005;41:1621. CrossRef

29. KulkarniS, PatsuteS, SaneS, et al. Enteric pathogens in HIV infected and HIV uninfected individuals with diarrhea in Pune. Trans R Soc Trop Med Hyg2013;107:648. CrossRef

30. MacArthurRD, DuPontHL. Etiology and pharmacologic management of noninfectious diarrhea in HIV‐infected individuals in the highly active antiretroviral therapy era. Clin Infect Dis2012;55:860. CrossRef

31. MacallanDC, NobleC, BaldwinC, et al. Energy expenditure and wasting in human immunodeficiency virus infection. NEJM1995;333:83. CrossRef

32. TheaDM, St. LouisME, AtidoU, et al. A prospective study of diarrhea and HIV‐1 infection among 429 Zairian infants. NEJM1993;329:1696. CrossRef

33. AndradeCS, JesusRP, AndradeTB, et al. Prevalence and characteristics associated with malnutrition at hospitalization among patients with acquired immunodeficiency syndrome in Brazil. PLoS ONE2012;7:e48717. CrossRef

34. WeberR, LedergerberB, ZbindenR, et al. Enteric infections and diarrhea in human immunodeficiency virus‐infected persons: prospective community‐based cohort study. Swiss HIV Cohort Study. Arch Intern Med1999;159:1473. CrossRef

35. KotlerDP, GiangTT, GarroML, et al. Light microscopic diagnosis of microsporidiosis in patients with AIDS. Am J Gastroenterol1994;89:540.

36. WilcoxCM, SchwartzDA, CotsonisG, et al. Chronic unexplained diarrhea in human immunodeficiency virus infection: determination of the best diagnostic approach. Gastroenterology1996;110:30. CrossRef

37. KotlerDP, OrensteinJM. Prevalence of intestinal microsporidiosis in HIV‐infected individuals referred for gastroenterologic evaluation. Am J Gastroenterol1994;89:1998.

38. GordinF, GibertC, SchmidtME. Clostridium difficile colitis associated with trimethoprim‐sulfamethoxazole given as prophylaxis for Pneumocystis carinii pneumonia. Am J Med1994;96:94. CrossRef

39. HainesCF, MooreRD, BartlettJG, et al. Clostridium difficile in a HIV‐Infected Cohort: incidence, risk factors, and clinical outcomes. AIDS2013;27:2799. CrossRef

40. BonnerJR, AlexanderWJ, DismukesWE, et al. Disseminated histoplasmosis in patients with the acquired immune deficiency syndrome. Arch Intern Med1984;144:2178. CrossRef

41. DeHovitzJA, PapeJW, BoncyM, et al. Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome. NEJM1986;315:87. CrossRef

42. CunninghamAL, GrohmanGS, HarknessJ, et al. Gastrointestinal viral infections in homosexual men who were symptomatic and seropositive for human immunodeficiency virus. J Infect Dis1988;158:386. CrossRef

43. KaljotKT, LingJP, GoldJWM, et al. Prevalence of acute enteric viral pathogens in acquired immuno‐ deficiency syndrome patients with diarrhea. Gastroenterology1989;97:1031.

44. SmithPD, QuinnTC, StroberW, et al. Gastrointestinal infections in AIDS. Ann Intern Med1992;116:63. CrossRef

45. GerdingDN, BrazierJS. Optimal methods for identifying Clostridium difficile infections. Clin Infect Dis1993;16:S439. CrossRef

46. DrydenMS, ShansonDC. The microbial causes of diarrhoea in patients infected with the human immunodeficiency virus. J Infect1988;17:107. CrossRef

47. JohansonJF, SonnenbergA. Efficient management of diarrhea in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med1990;112:942. CrossRef

48. BrownJW, SavidesTJ, MathewsC, et al. Diagnostic yield of duodenal biopsy and aspirate in AIDS‐associated diarrhea. Am J Gastroenterol1996;91:2289.

49. WilcoxCM, WaitesKB, SmithPD. No relationship between gastric pH, small bowel bacterial colonisation, and diarrhoea in HIV‐1 infected patients. Gut1999;44:101. CrossRef

50. ConnollyGM, ForbesA, GazzardBG. Investigation of seemingly pathogen‐negative diarrhoea in patients infected with HIV1. Gut1990;31:886. CrossRef

51. BensonCA, KaplanJE, MasurH, et al. Treating opportunistic infections among HIV‐exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. Clin Infect Dis2005;40:S131. CrossRef

52. MacarthurRD, HawkinsTN, BrownSJ, et al. Efficacy and safety of crofelemer for noninfectious diarrhea in HIV‐seropositive individuals (ADVENT trial): a randomized, double‐blind, placebo‐controlled, two‐stage study. HIV Clin Trials2013;14:261. CrossRef

53. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV‐1‐infected adults and adolescents. Department of Health and Human Services, 2014. Available at: http://aidsinfo.nih.gov/guidelines.

54. SchmidtW, WahnschaffeU, SchäferM, et al. Rapid increase of mucosal CD4 T‐cells followed by clearance of intestinal cryptosporidiosis in an AIDS patient receiving highly active antiretroviral therapy. Gastroenterology2001;120:984. CrossRef

55. CarrA, MarriottD, FieldA, et al. Treatment of HIV‐1‐associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy [see comments]. Lancet1998;351:256. CrossRef

56. MönkemüllerKE, CallSA, LazenbyAJ, et al. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy. Am J Gastroenterol2000;95:457. CrossRef

57. CassoneA, TacconelliE, De BernardisF, et al. Antiretroviral therapy with protease inhibitors has an early, immune reconstitution‐independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus‐infected subjects. J Infect Dis2002;185:188. CrossRef

58. CurrierJS, WilliamsPL, KoletarSL, et al. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy‐induced increases in CD4+ cell count. Ann Intern Med2000;133:493. CrossRef

59. FurrerH, EggerM, OpravilM, et al. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV‐1‐infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. NEJM1999;340:1301. CrossRef

60. MussiniC, PezzottiP, GovoniA, et al. Discontinuation of primary prophylaxis for Pneumonocystis carinii pneumonia and toxoplasmic incephalitis in human immunodeficiency virus type 1‐infected patietns: the changes in oppourtunistic prophylaxis study. J Infect Dis2000;181:1635. CrossRef

61. GordonMA. Invasive nontyphoidal Salmonella disease: epidemiology, pathogenesis and diagnosis. Curr Opin Infect Dis2011;24:484. CrossRef

62. PithieAD, MalinAS, RobertsonVJ. Salmonella and Shigella bacteraemia in Zimbabwe. Cent Afr J Med1993;39:110.

63. NelsonMR, ShansonDC, HawkinsD, et al. Shigella in HIV infection. AIDS1991;5:1031. CrossRef

64. TeeW, MijchA. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)‐infected and non‐HIV‐infected patients: comparison of clinical features and review. Clin Infect Dis1998;26:91. CrossRef

65. SnifjersF, KuijperEJ, de WeverB, et al. Prevalence of Campylobacter‐associated diarrhea among patients infected with human immunodeficiency virus. Clin Infect Dis1997;24:1107. CrossRef

66. OrensteinJM, FoxC, WahlSM. Macrophages as a source of HIV during opportunistic infections. Science1997;276:1857. CrossRef

67. NewmanGW, KelleyGH, GanH, et al. Concurrent infection of human macrophages with HIV‐1 and Mycobacterium avium results in decreased cell viability, increased M. avium multiplication and altered cytokine production. J Immunol1993;151:2261.

68. GrayJR, RabeneckL. Atypical mycobacterial infection of the gastrointestinal tract in AIDS patients. Am J Gastroenterol1989;84:1521.

69. HorsburghCRJ. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. NEJM1991;324:1332. CrossRef

70. SmithPD, OhuraK, MasurH, et al. Monocyte function in the acquired immune deficiency syndrome: Defective chemotaxis. J Clin Invest1984;74:2121. CrossRef

71. BensonCA, WilliamsPL, CurrierJS, et al. A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome. Clin Infect Dis2003;37:1234. CrossRef

72. UthmanMM, UthmanOA, YahayaI. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV. Cochrane Database Syst Rev2013;(4):CD007191.

73. CozartJC, KalangiSS, ClenchMH, et al. Clostridium difficile diarrhea in patients with AIDS versus non‐AIDS controls. Methods of treatment and clinical response to treatment. J Clin Gastroenterol1993;16:192. CrossRef

74. PachecoSM, JohnsonS. Important clinical advances in the understanding of Clostridium difficile infection. Curr Opin Gastroenterol2013;29:42. CrossRef

75. SivapalasingamS, BlaserMJ. Bacterial diarrhea in HIV‐infected patients: why Clostridium difficile, and why now?Clin Infect Dis2005;41:1628. CrossRef

76. LouieTJ, MillerMA, MullaneKM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. NEJM2011;364:422. CrossRef

77. KotlerDP, OrensteinJM. Diarrhea and malabsorption due to enterocyte‐adherent bacterial infection in a patient with AIDS. Ann Intern Med1993;116:127. CrossRef

78. KotlerDP, OrensteinJM. Chronic bacterial enteropathy in patients with AIDS. J Infect Dis1995;171:552. CrossRef

79. SamieA, ObiCL, DillinghamR, et al. Enteroaggregative Escherichia coli in Venda, South Africa: distribution of virulence‐related genes by multiplex polymerase chain reaction in stool samples of human immunodeficiency virus (HIV)‐positive and HIV‐negative individuals and primary school children. Am J Trop Med Hyg2007;77:142.

80. WankeCA, GerriorJ, BlaisV, et al. Successful treatment of diarrheal disease associated with enteroaggregative Escherichia coli in adults infected with human immunodeficiency virus. J Infect Dis1998;178:1369. CrossRef

81. RelmanDA. Molecular phylogenetic analysis of Cyclospora, the human intestinal pathogen, suggests that it is closely related to eimeria species. J Infect Dis1996;173:440. CrossRef

82. FlaniganT, WhalenC, TurnerJ, et al. Cryptosporidium infection and CD4 counts. Ann Intern Med1992;116:840. CrossRef

83. NavinTR, WeberR, VugiaDJ, et al. Declining CD4+ T‐lymphocyte counts are associated with increased risk of enteric parasitosis and chronic diarrhea: results of a 3‐year longitudinal study. J Acquir Immune Defic Syndr1999;20:154. CrossRef

84. WolfsonJS, RichterJM, WaldronMA, et al. Cryptosporidiosis in immunocompetent patients. NEJM1985;312:1278. CrossRef

85. MacKenzieWR, HoxieNJ, ProctorME, et al. A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply. NEJM1994;331:161. CrossRef

86. JanoffEN, LimasC, GebhardRL. Cryptosporidial carriage without symptoms in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med1990;112:75. CrossRef

87. HunterPR, NicholsG. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev2002;15:145. CrossRef

88. BlackmanE, BinderS, GaultierC, et al. Cryptosporidiosis in HIV‐infected patients: diagnostic sensitivity of stool examination, based on number of specimens submitted. Am J Gastroenterol1997;92:451.

89. HewittRG, YiannoutsosCT, HiggsES, et al. Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group. Clin Infect Dis2000;31:1084. CrossRef

90. RossignolJF, HidalgoH, FeregrinoM, et al. A double‐′blind′ placebo‐controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans R Soc Trop Med Hyg1998;92:663. CrossRef

91. RossignolJ‐FA, AyoubA, AyersMS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double‐blind, placebo‐controlled study of Nitazoxanide. J Infect Dis2001;184:103. CrossRef

92. AbubakarI, AliyuSH, ArumugamC, et al. Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta‐analysis. Br J Clin Pharmacol2007;63:387. CrossRef

93. IvesNJ, GazzardBG, EasterbrookPJ. The changing pattern of AIDS‐defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic. J Infect Dis2001;42:134.

94. ConlonCP, PinchingAJ, PereraCU, et al. HIV‐related enteropathy in Zambia: A clinical microbiological and histological study. Am J Trop Med Hyg1990;42:83.

95. NgE, MarkellEK, FlemingRI, et al. Demonstration of Isospora belli by acid‐fast stain in a patient with acquired immune deficiency syndrome. J Clin Microbiol1984;20:384.

96. OrtegaYR, SterlingCR, GilmanRH, et al. Cyclospora species ‐ A new protozoan pathogen of humans. NEJM1993;328:1308. CrossRef

97. OrtegaYR, NagleR, GilmanRH, et al. Pathological and clinical findings in patients with cyclosporiasis and a description on intracellular parpasite life‐cycle stages. J Infect Dis1997;176:1584. CrossRef

98. PapeJW, VerdierR‐I, BoncyM, et al. Cyclospora infection in adults infected with HIV. Clinical manifestations, treatment, and prophylaxis. Ann Intern Med1994;121:654. CrossRef

99. HuangP, WeberJT, SosinDM, et al. The first reported outbreak of diarrheal illness associated with cyclospora in the United States. Ann Intern Med1995;123:409. CrossRef

100. HerwaldtBL, AckersM‐L. and Cyclosporidia Working Group. An outbreak in 1996 of cyclosporiasis associated with imported raspberries. NEJM1997;336:1548. CrossRef

101. JanoffEN, SmithPD, BlaserMJ. Acute antibody responses to Giardia lamblia are depressed in patients with the acquired immunodeficiency syndrome. J Infect Dis1988;157:798. CrossRef

102. HungCC, DengHY, HsiaoWH, et al. Invasive amebiasis as an emerging parasitic disease in patients with human immunodeficiency virus type 1 infection in Taiwan. Arch Intern Med2005;165:409. CrossRef

103. RiceGPA, SchrierRD, OldstoneMBA. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate early antigen products. Proc Natl Acad Sci U S A1984;81:613.

104. SicilianoRF, CastelliJB, RandiBA, et al. Cytomegalovirus colitis in immunocompetent critically ill patients. Int J Infect Dis2014;20:71. CrossRef

105. GentaRM, BleyzerI, CateTR, et al. In situ hybridization and immunohistochemical analysis of cytomegalovirus‐associated ileal perforation. Gastroenterology1993;104:1822.

106. SmithPD, SainiSS, RaffeldM, et al. Cytomegalovirus induction of tumor necrosis factor‐alpha by human monocytes and mucosal macrophages. J Clin Invest1992;90:1642. CrossRef

107. RedmanTK, BrittWJ, WilcoxCM, et al. Human cytomegalovirus enhances chemokine production by lipopolysaccharide‐stimulated lamina propria macrophages. J Infect Dis2002;185:584. CrossRef

108. DieterichDT, RahminM. Cytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literature. J Acquir Immune Defic Syndr1991;4:S29.

109. Culpepper‐MorganJA, KotlerDP, ScholesJV, et al. Evaluation of diagnostic criteria for mucosal cytomegalic inclusion disease in the acquired immune deficiency syndrome. Am J Gastroenterol1987;82:1264.

110. WohlDA, KendallMA, AndersonJ, et al. Low rate of CMV end‐organ disease in HIV‐infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030. HIV Clin Trials2009;10:143. CrossRef

111. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for Prevention and Treatment of Opportunistic Infections in HIV‐Infected Adults and Adolescents. Department of Health and Human Services, 2014. Available at: http://aidsinfo.nih.gov/guidelines.

112. SiegalFP, LopezC, HammerGS, et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. NEJM1981;305:1439. CrossRef

113. StrickLB, WaldA, CelumC. Management of herpes simplex virus type 2 infection in HIV type 1‐infected persons. Clin Infect Dis2006;43:347. CrossRef

114. JanoffEN, OrensteinJM, ManischewitzJF, et al. Adenovirus colitis in the acquired immunodeficiency syndrome. Gastroenterology1991;100:976.

115. IsonMG. Adenovirus infections in transplant recipients. Clin Infect Dis2006;43:331. CrossRef

116. GrohmannGS, GlassRI, PereiraHG, et al. Enteric viruses and diarrhea in HIV‐infected patients. NEJM1993;329:14. CrossRef

117. TheaDM, GlassR, GrohmannGS, et al. Prevalence of enteric viruses among hospital patients with AIDS in Kinshasa, Zaire. Trans R Soc Trop Med Hyg1993;87:263. CrossRef

118. OshitaniH, KasoloFC, MpabalwaniM, et al. Association of rotavirus and human immunodeficiency virus infection in children hospitalized with acute diarrhea, Lusaka, Zambia. J Infect Dis1994;169:897. CrossRef

119. CaliA, OwenRL. Intracellular development of Enterocytozoon, a unique microsporidian found in the intestine of AIDS patients. J Protozool1990;37:145. CrossRef

120. OrensteinJM, DieterichDT, KotlerDP. Systemic dissemination by a newly recognized intestinal microsporidia species in AIDS. AIDS1992;6:1143. CrossRef

121. OrensteinJM, TennerM, CaliA, et al. A microsporidian previously undescribed in humans, infecting enterocytes and macrophages, and associated with diarrhea in an acquired immunodeficiency syndrome patient. Hum Pathol1992;23:722. CrossRef

122. MolinaJM, OksenhendlerE, BeauvaisB, et al. Disseminated microsporidiosis due to Septata intestinalis in patients with AIDS: Clinical features and response to albendazole therapy. J Infect Dis1995;171:245. CrossRef

123. GumboT, HobbsRE, CarlynC, et al. Microsporidia infection in transplant patients. Transplantation1999;67:482. CrossRef

124. GoetzM, EichenlaubS, PapeGR, et al. Chronic diarrhea as a result of intestinal microsporidiosis in a liver transplant recipient. Transplantation2001;71:334. CrossRef

125. MullerA, BialekR, KamperA, et al. Detection of microsporidia in travelers with diarrhea. J Clin Microbiol2001;39:1630. CrossRef

126. KottonCN. Life‐saving organ transplants accompanied by stealthy and unexpected pathogens. Ann Intern Med2014;160:282. CrossRef

127. BernC, KawaiV, VargasD, et al. The epidemiology of intestinal microsporidiosis in patients with HIV/AIDS in Lima, Peru. J Infect Dis2005;191:1658. CrossRef

128. MolinaJM, SarfatiC, BeauvaisB, et al. Intestinal microsporidiosis in human immunodeficiency virus‐infected patients with chronic unexplained diarrhea: prevalence and clinical and biological features. J Infect Dis1993;167:217. CrossRef

129. OrensteinJM, TennerM, KotlerDP. Localization of infection by the microsporidian Enterocytozoon bienusi in the gastrointestinal tract of AIDS patients with diarrhea. AIDS1992;6:195. CrossRef

130. MolinaJM, ChastangC, GoguelJ, et al. Albendazole for treatment and prophylaxis of microsporidiosis due to Encephalitozoon intestinalis in patients with AIDS: a randomized double‐blind controlled trial. J Infect Dis1998;177:1373. CrossRef

131. WheatLJ, Connolly‐StringfieldP, KohlerRB, et al. Histoplasma capsulatum polysaccharide antigen detection in diagnosis and management of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med1989;87:396. CrossRef

132. GutierrezME, CantonA, SosaN, et al. Disseminated histoplasmosis in patients with AIDS in Panama: a review of 104 cases. Clin Infect Dis2005;40:1199. CrossRef

133. AssiM, McKinseyDS, DriksMR, et al. Gastrointestinal histoplasmosis in the acquired immunodeficiency syndrom: report of 18 cases and literature review. Diagn Micrbiol Infect Dis2006;55:195. CrossRef

134. KarimiK, WheatLJ, ConnollyP, et al. Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the United States and Brazil. J Infect Dis2002;186:1655. CrossRef

135. McKinseyDS, GuptaMR, RiddlerSA, et al. Long‐term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med1989;111:655. CrossRef

136. MargulisSJ, HonigCL, SoaveR, et al. Biliary tract obstruction in the acquired immunodeficiency syndrome. Ann Intern Med1986;105:207. CrossRef

137. SchneidermanDJ, CelloJP, LaingFC. Papillary stenosis and sclerosing cholangitis in the acquired immunodeficiency syndrome. Ann Intern Med1987;106:546. CrossRef

138. PolS, RomanaCA, RichardS, et al. Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis. NEJM1993;328:95. CrossRef

139. BenatorDA, FrenchAL, BeaudetLM, et al. Isospora belli infection associated with acalculous cholecystitis in a patient with AIDS. Ann Intern Med1994;121:663. CrossRef

140. PolS, RomanaC, RichardS, et al. Enterocytozoon bieneusi infection in acquired immunodeficiency syndrome‐related sclerosing cholangitis. Gastroenterolgy1992;102:1778.

141. BonaciniM. Pancreatic involvement in human immunodeficiency virus infection. J Clin Gastroenterol1991;13:58. CrossRef

142. JoeL, AnsherAF, GordinFM. Severe pancreatitis in an AIDS patient in association with cytomegalovirus infection. South Med J1989;82:1444. CrossRef

143. JaberB, GleckmanR. Tuberculous panceratic abscess as an initial AIDS‐defining disorder in a patient infected with the human immunodeficiency virus: case report and review. Clin Infect Dis1995;20:890. CrossRef

144. CappellMS, MarksM. Acute pancreatitis in HIV‐seropositive patients: a case control study of 44 patients. Am J Med1995;98:243. CrossRef

145. UzzanB, BentataM, CamposJ, et al. Effects of aerosolized pentamidine on glucose homeostasis and insulin secretion in HIV‐positive patients: a controlled study. AIDS1995;9:901. CrossRef

146. SeidlinM, LambertJS, DolinR, et al. Pancreatitis and pancreatic dysfunction in patients taking dideoxyinosine. AIDS1992;6:831. CrossRef

147. MaxsonCJ, GreenfieldSM, TurnerJL. Acute pancreatitis as a common complication of 2′, 3′‐Dideoxyinosine therapy in the acquired immunodeficiency syndrome. Am J Gastroenterol1992;87:708.

148. PezzilliR, GulloL, RichhiE, et al. Serum pancreatic enzymes in HIV‐seropositive patients. Dig Dis Sci1992;37:286. CrossRef

149. BoixV, PortillaJ, MerinoE, et al. Origin of hyperamylasaemia in HIV‐infected patients. AIDS1996;10:553. CrossRef

150. ParenteF, CernuschiM, ValsecchiL, et al. Acute upper gastrointestinal bleeding in patients with AIDS: a relatively uncommon condition associated with reduced survival. Gut1991;32:987. CrossRef

151. CappellMS, GellerAJ. The high mortality of gastrointestinal bleeding in HIV‐seropositive patients: a multivariate analysis of risk factors and warning signs of mortality in 50 consecutive patients. Am J Gastroenterol1992;87:815.

152. WilcoxCM, SchwartzDA, ClarkWS. Esophageal ulceration in human immunodeficiency virus infection. Causes, response to therapy, and long‐term outcome. Ann Intern Med1995;122:143. CrossRef

153. WilcoxCM, StraubRF, SchwartzDA. Cytomegalovirus esophagitis in AIDS: A prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long‐term outcome. Am J Med1995;98:169. CrossRef

154. BlackmanE, VimadalalS, NashG. Significance of gastrointestinal cytomegalovirus infection in homosexual males. Am J Gastroenterol1984;79:935.

155. EvansJD, RobertsonCS, ClagueMB, et al. Severe lower gastrointestinal haemorrhage from cytomegalovirus ulceration of the terminal ileum in a patient with AIDS. Eur J Surg1993;159:373.

156. SelikRM, ChuSY, WardJW. Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992. Ann Intern Med1995;123:933. CrossRef

157. ChangY, CesarmanE, PessinMS, et al. Identification of herpesvirus‐like DNA sequences in AIDS‐associated Kaposi's sarcoma. Science1994;266:1865. CrossRef

158. AmbroziakJA, BlackbournDJ, HerndierBG, et al. Herpes‐like sequences in HIV‐infected and uninfected Kaposi's sarcoma patients. Science1995;268:582. CrossRef

159. CesarmanE, ChangY, MoorePS, et al. Kaposi's sarcoma‐associated herpesvirus‐like DNA sequences in AIDS‐related body‐cavity‐based lymphomas. NEJM1995;332:1186. CrossRef

160. GaoS‐J, KinsleyL, HooverDR, et al. Seroconversion to antibodies against Kaposi's sarcoma‐associated herpesvirus‐related latent nuclear antigens before the development of Kaposi's sarcoma. NEJM1996;335:233. CrossRef

161. SaltzRK, KurtzRC, LightdaleCJ, et al. Kaposi's sarcoma. Gastrointestinal involvement correlation with skin findings and immunologic function. Dig Dis Sci1984;29:817. CrossRef

162. FriedmanSL, WrightTL, AltmanDF. Gastrointestinal Kaposi's sarcoma in pationts with acquired immunodeficiency syndrome. Gastroenterology1985;89:102.

163. GelmannEP, PrebleOT, SteisR, et al. Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters. Am J Med1985;78:737. CrossRef

164. HarrisonM, TomlinsonD, StewartS. Liposomal‐entrapped doxorubicin: an active agent in AIDS‐related Kaposi's sarcoma. J Clin Oncol1995;13:914.

165. BeckPL, GillMJ, SutherlandLR. HIV‐associated non‐Hodgkin's lyphoma of the gastrointestinal tract. Am J Gastroenterol1996;91:2377.

166. SteinbergJJ, BridgesN, FeinerJD, et al. Small intestinal lymphoma in three patients with acquired immune deficiency syndrome. J Gastroenterol1985;80:21.

167. DanzigJB, BrandtLJ, ReinusJF, et al. Gastrointestinal malignancy in patients with AIDS. Am J Gastroenterol1991;86:715.

168. KatzBZ, Raab‐TraubN, MillerG. Latent and replicating forms of Epstein‐Barr virus DNA in lymphomas and lymphoproliferative diseases. J Infect Dis1989;160:589. CrossRef

169. CaussyD, GoedertJJ, PalefskyJ, et al. Interaction of human immunodeficiency and papilloma viruses: association with anal epithelial abnormality in homosexual men. Int J Cancer1990;46:214. CrossRef

170. DalingJR, WeissNS, HislopTG, et al. Sexual practices, secually transmitted diseases, and the incidence of anal cancer. NEJM1987;317:973. CrossRef

171. PalefskyJM, HollayEA, GonzalesJ, et al. Natural history of anal cytologic abnormalities and papillomavirus infection among homosexual men with group IV HIV disease. J Acquir Immune Defic Syndr1992;5:1258. CrossRef

172. GarlandSM, Hernandez‐AvilaM, WheelerCM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. NEJM2007;356:1928. CrossRef

173. LawCLH, QassimM, CunninghamAL, et al. Nonspecific proctitis: Association with human immunodeficiency virus infection in homosexual men. J Infect Dis1992;165:150. CrossRef

174. VerleyJR, QuinnTC. Sexually transmitted infections of the anus and rectum. In: BlaserMJ, SmithPD, RavdinJI, et al. (eds). Infections of the Gastrointestinal Tract. New York: Raven Press, 1995: 411.

175. WilcoxCM, SchwartzDA. Idiopathic anorectal ulceration in patients with human immunodeficiency virus infection. Am J Gastroenterol1994;89:599.

176. AmpelNM, StoutML, GarewalHS, et al. Persistent rectal ulcer associated with human papillomavirus type 33 in a patient with AIDS: successful treatment with isotretinoin. Rev Infect Dis1990;12:1004. CrossRef

177. KiviatN, RompaloA, BowdenR, et al. Anal human papillomavirus infection among human immunodeficiency virus‐seropositive and ‐seronegative men. J Infect Dis1990;162:358. CrossRef

178. Puy‐MontbrunT, GanansiaR, LemarchandN, et al. Anal ulcerations due to cytomegalovirus in patients with AIDS. Report of six cases. Dis Colon Rectum1990;33:1041. CrossRef

179. WeissEG, WexnerSD. Surgery for anal lesions in HIV‐infected patients. Ann Med1995;27:467. CrossRef

180. LorenzHP, WilsonW, LeighB, et al. Squamous cell carcinoma of the anus and HIV infection. Dis Colon Rectum1991;34:336. CrossRef

181. ShlomchikWD. Graft‐versus‐host disease. Nat Rev Immunol2007;7:340. CrossRef

182. SpencerGD, HackmanRC, McDonaldGB, et al. A prospective study of unexplained nausea and vomiting after marrow transplantation. Transplantation1986;42:602. CrossRef

183. WeisdorfDJ, SnoverDC, HaakeR, et al. Acute upper gastrointestinal graft‐versus‐host disease: clinical significance and response to immunosuppressive therapy. Blood1990;76:624.

184. TobinRW, HackmanRC, KimmeyMB, et al. Bleeding from gastric antral vascular ectasia in marrow transplant patients. Gastrointest Endosc1996;44:223. CrossRef

185. RoyJ, SnoverD, WeisdorfS, et al. Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft‐versus‐host disease. Transplantation1991;51:642. CrossRef

186. BombiJA, NadalA, CarrerasE, et al. Assessment of histopathologic changes in the colonic biopsy in acute graft‐versus‐host disease. Am J Clin Pathol1995;103:690.

187. McDonaldGB, ShulmanHM, WolfordJL, et al. Liver disease after human marrow transplantation. Semin Liver Dis1987;7:210. CrossRef

188. ShulmanHM, SharmaP, AmosD, et al. A coded histologic study of hepatic graft‐versus‐host disease after human bone marrow transplantation. Hepatology1988;8:463. CrossRef

189. McDonaldGB, SullivanKM, SchufflerMD, et al. Esophageal abnormalities in chronic graft‐versus‐host disease in humans. Gastroenterology1981;80:914.

190. KinnebrewMA, LeeYJ, JenqRR, et al. Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation. PLoS ONE2014;9:e90158. CrossRef

191. DadwalSS, TegtmeierB, NakamuraR, et al. Nontyphoidal Salmonella infection among recipients of hematopoietic SCT. Bone Marrow Transplant2011;46:880. CrossRef

192. KronesE, HogenauerC. Diarrhea in the immunocompromised patient. Gastroenterol Clin North Am2012;41:677. CrossRef

193. PantC, DeshpandeA, LarsonA, et al. Diarrhea in solid‐organ transplant recipients: a review of the evidence. Curr Med Res Opin2013;29:1315. CrossRef

194. LubetkinEI, LipsonDA, PalevskyHI, et al. GI complications after orthotopic lung transplantation. Am J Gastroenterol1996;91:2382.

195. FishmanJA. Infection in solid‐organ transplant recipients. NEJM2007;357:2601. CrossRef

196. WheatLJ, SmithEJ, SathapatayavongsB, et al. Histoplasmosis in renal allograft recipients. Two large urban outbreaks. Arch Intern Med1983;143:703. CrossRef

197. BrettMT, KwanJT, BendingMR. Caecal perforation in a renal transplant patient with disseminated histoplasmosis. J Clin Pathol1988;41:992. CrossRef

198. MartinoP, GentileG, CaprioliA, et al. Hospital‐acquired cryptosporidiosis in a bone marrow transplantation unit. J Infect Dis1988;158:647. CrossRef

199. RoncoroniAJ, GomezMA, MeraJ, et al. Cryptosporidium infection in renal transplant patients. J Infect Dis1989;160:559. CrossRef

200. MutimerD. CMV infection of transplant recipients. J Hepatol1996;25:259. CrossRef

201. HofflinJM, PotasmanI, BaldwinJC, et al. Infectious complications in heart transplant recipients receiving cyclosporin and corticosteroids. Ann Intern Med1987;106:209. CrossRef

202. GorensekMJ, StewartRW, KeyTF, et al. A multivariate analysis of the risk of cytomegalovirus infection in heart transplant recipients. J Infect Dis1988;157:515. CrossRef

203. KaplanCS, PetersenEA, IcenogleTB, et al. Gastrointestinal cytomegalovirus infection in heart and heart‐lung transplant recipients. Arch Intern Med1989;149:2095. CrossRef

204. FalagasME, SnydmanDR, GriffithJ, et al. Effect of cytomegalovirus infection status on first‐year mortality rates among orthotopic liver transplant recipients. Ann Intern Med1997;126:275. CrossRef

205. MeyersJD, FlournoyN, ThomasED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis1986;153:478. CrossRef

206. MorganJS, SchaffnerW, StoneWJ. Opportunistic strongyloidiasis in renal transplant recipients. Transplantation1986;42:518. CrossRef

207. StoneWJ, SchaffnerW. Strongyloides infections in transplant recipients. Semin Respir Infect1990;5:58.

208. GuecoI, MendozaSM, AlanoF, et al. Tropical infections after renal transplantation. Transplant Proc1989;21:2105.

209. SinghN, DummerJS, KusneS, et al. Infections with cytomegalovirus and other herpex viruses in 121 liver transplant recipients: transmission by donated organ and ethe effect of OKT3 antibodies. J Infect Dis1988;158:124. CrossRef

210. KirstilaV, SewonL, LaineJ. Periodontal disease in three siblings with familial neutropenia. J Peridontol1993;64:566. CrossRef

211. KatzJA, WagnerML, GresikMV, et al. Typhlitis. An 18‐year experience and postmortem review. Cancer1990;65:1041. CrossRef

212. NewboldKM. Neutropenic enterocolitis. Clinical and pathological review. Dig Dis1989;7:281. CrossRef

213. RolstonKV, BodeyGP, SafdarA. Polymicrobial infection in patients with cancer: an underappreciated and underreported entity. Clin Infect Dis2007;45:228. CrossRef

214. TillM, LeeN, SoperWD, et al. Typhlitis in patients with HIV‐1 infection. Ann Intern Med1992;116:998. CrossRef